OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.480
-0.030 (-1.99%)
At close: Jan 8, 2025, 4:00 PM
1.461
-0.020 (-1.32%)
After-hours: Jan 8, 2025, 7:52 PM EST
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.75, with a low estimate of 2.25 and a high estimate of 3.00. The average target predicts an increase of 85.81% from the current stock price of 1.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +102.70% | Jan 8, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +52.03% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +102.70% | Sep 26, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +52.03% | Sep 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $3 | Buy | Reiterates | $3 | +102.70% | Sep 17, 2024 |
Financial Forecast
Revenue This Year
691.76M
from 863.50M
Decreased by -19.89%
Revenue Next Year
691.77M
from 691.76M
Increased by 0.00%
EPS This Year
-0.19
from -0.25
EPS Next Year
-0.29
from -0.19
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 720.4M | 797.3M | 839.0M |
| Avg | 691.8M | 691.8M | 741.5M |
| Low | 668.4M | 625.2M | 669.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -16.6% | 15.3% | 21.3% |
| Avg | -19.9% | 0.0% | 7.2% |
| Low | -22.6% | -9.6% | -3.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.18 | -0.05 | 0.02 |
| Avg | -0.19 | -0.29 | -0.11 |
| Low | -0.24 | -0.53 | -0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.